The global acne treatment market, valued at US$ 13.44 billion in 2023, is projected to reach US$ 23.33 billion by 2034, growing at a CAGR of 5.14%. This growth is driven by the rising prevalence of skin issues linked to poor diet, unhealthy lifestyles, and hormonal imbalances, along with innovations in effective treatment options.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5309
With the changing lifestyles, people of all age groups may suffer from skin problems like acne that need proper medications and treatments to avoid the severity of those conditions. Dermatologists play major roles in providing suitable preventive measures to patients through topical medications, oral medications, or therapies. These medicines help in the reduction of produced oils and swelling due to bacterial infections or other common scenarios. Topical medications commonly include retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, or dapsone gel.
Therapeutic Class Insights
In 2023, the retinoid segment led the global acne medicine market due to its widespread use and proven effectiveness in treating acne. Retinoids work by preventing clogged pores and reducing inflammation, key contributors to acne. They are commonly found in creams, gels, and lotions, making them suitable for all skin types. Popular retinoids like retinol, tretinoin, adapalene, tazarotene, and bexarotene are not only used for acne but also for treating fine wrinkles and hyperpigmentation. Dermatologists often prescribe them for mild to moderate acne cases.
Formulation Insights
The topical medication segment dominated the market in 2023, as creams, gels, and lotions are easy to apply directly to affected skin areas. In addition to retinoids, antibiotics like erythromycin and clindamycin are commonly used for topical acne treatments. These treatments can be effective for weeks or even months. A popular combination strategy involves using topical antibiotics with benzoyl peroxide and retinoids to prevent bacterial resistance.
Type Insights
Prescription medicines held the largest share in 2023, thanks to their higher concentrations of active ingredients and more advanced formulations. Oral antibiotics, like azithromycin and tetracycline, are often prescribed for acne that doesn’t respond to topical treatments. Hormonal therapies, such as oral contraceptives, are also used to control sebum production and treat acne, especially in women, adolescents, and adults.
Acne Type Insights
Non-inflammatory acne dominated the market in 2023, as it is the most common form, particularly among teenagers and young adults. Acne vulgaris can present with both inflammatory and non-inflammatory lesions. Blackheads and whiteheads, typical of non-inflammatory acne, are the most prevalent types that don’t cause swelling or irritation.
Distribution Channel Insights
Pharmacies and drug stores were the leading distribution channels in 2023, due to their widespread availability and convenience for consumers. Many acne treatments can be purchased over the counter, making them easily accessible without a prescription, which further boosts their popularity.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/acne-medicine-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5309
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Seoul, South Korea Lotte Biologics is making significant strides in expanding its global presence in the Contract Development and Manufacturing… Read More
The medical imaging market is witnessing rapid expansion worldwide, and Europe is emerging as a key contributor to this global… Read More
The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada… Read More
The surgical sutures market in the United States is showing steady and promising growth, and here’s why! 👇 👵👴 An… Read More
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More